Analysis of various etiologies of hypertension in patients hospitalized in the endocrinology division

Endocrine

Volumn 42, Issue 1, 2012, Pages 174-181

  Ye, Dan ^a   Dong, FengQin ^a   Lu, XunLiang ^a   Zhang, Zhe ^a   Feng, YunFei ^a   Li, ChengJiang ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Cause analysis; Endocrinology; Essential hypertension; Secondary hypertension

Indexed keywords

ALDOSTERONE; CREATININE; PROTEIN; RENIN;

ADOLESCENT; ADRENAL HYPERTENSION; ADRENAL TUMOR; ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CENTRAL HYPERTENSION; CREATININE BLOOD LEVEL; CUSHING SYNDROME; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DISEASE DURATION; ENDOCRINOLOGY; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FATTY LIVER; FEMALE; HOSPITAL DEPARTMENT; HOSPITAL PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PSYCHOGENIC HYPERTENSION; RENAL ARTERY HYPERTENSION; RENOVASCULAR HYPERTENSION; RISK FACTOR;

EID: 84865019951     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-011-9588-5     Document Type: Article

References (29)

1. P.M. Kearney, M. Whelton, K. Reynolds et al., Global burden of hypertension: analysis of worldwide data Hypertension: uncontrolled and conquering the world. Lancet 365(9455), 217-223 (2005)
2. M. Omura, J. Saito, K. Yamaguchi et al., Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan. Hypertens. Res. 27(3), 193-202 (2004)
3. N. Sukor, Secondary hypertension: a condition not to be missed. Postgrad. Med. J. 87(1032), 706-713 (2011)
4. P. Mulatero, M. Stowasser, K.C. Loh et al., Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents. J. Clin. Endocrinol. Metab. 89(3), 1045-1050 (2004)
5. L. Mosso, C. Carvajal, A. Gonzalez et al., Primary aldosteronism and hypertensive disease. Hypertension 42(2), 161-165 (2003)
6. O. Olivieri, A. Ciacciarelli, D. Signorelli et al., Aldosterone to renin ratio in a primary care setting: the Bussolengo study. J. Clin. Endocrinol. Metab. 89(9), 4221-4226 (2004)
7. J.W. Lenders, G. Eisenhofer, M. Mannelli et al., Phaeochromocytoma. Lancet 366(9486), 665-675 (2005)
8. G. Eisenhofer, D.S. Goldstein, M.M. Walther et al., Biochemical diagnosis of pheochromocytoma: how to distinguish true from false-positive test results. J. Clin. Endocrinol. Metab. 88(6), 2656-2666 (2003)
9. G. Arnaldi, A. Angeli, A.B. Atkinson et al., Diagnosis and complications of Cushing's syndrome: a consensus statement. J. Clin. Endocrinol. Metab. 88(12), 5593-5602 (2003)
10. J.W. Findling, H. Raff, D.C. Aron, The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. J. Clin. Endocrinol. Metab. 89(3), 1222-1226 (2004)
11. M.O. Salifu, D.M. Haria, O. Badero et al., Challenges in the diagnosis and management of renal artery stenosis. Curr. Hypertens. Rep. 7(3), 219-227 (2005)
12. H.P. Baglivo, R.A. Sánchez, Secondary arterial hypertension: improvements in diagnosis and management in the last 10 years. Am. J. Ther. 18(5), 403-415 (2011)
13. A.J. Viera, D.M. Neutze, Diagnosis of secondary hypertension: an age-based approach.Am. Fam. Physician 82(12), 1471-1478 (2010)
14. X.L. Luo, T.L. Yang, X.P. Chen et al., Association of CALCA genetic polymorphism with essential hypertension. Chin. Med. J. 121(15), 1407-1410 (2008)
15. T. Ueno, M. Soma, Y. Tabara et al., Association between fatty acid binding protein 3 gene variants and essential hypertension in humans. Am. J. Hypertens. 21(6), 691-695 (2008)
16. R. Stamler, J. Stamler, W.F. Riedlinger et al., Family (parental) history and prevalence of hypertension. Results of a nationwide screening program. JAMA 241(1), 43-46 (1979)
17. I.B. Goldstein, D. Shapiro, D. Guthrie, Ambulatory blood pressure and family history of hypertension in healthy men and women. Am. J. Hypertens. 19(5), 486-491 (2006)
18. T. Shirakawa, R. Ozono, F. Kasagi et al., Differential impact of family history on age-associated increase in the prevalence of hypertension and diabetes in male Japanese workers (J). Hypertens. Res. 29(2), 81-87 (2006)
19. E. D'Adamo, A.M. Cali, R. Weiss et al., Central role of fatty liver in the pathogenesis of insulin resistance in obese adolescents. Diabetes Care 33(8), 1817-1822 (2010)
20. A. Whaley-Connell, J.R. Sowers, Hypertension and insulin resistance. Hypertension 54(3), 462-464 (2009)
21. V. Lamounier-Zeprer, M. Vehrhart-Bornstein, S.R. Bornstein, Insulin resistance in hypertension and cardiovascular disease. Best Pract. Res. Clin. Endocrinol. Metab. 20(3), 355-367 (2006)
22. M.A. Zeiger, S.S. Siegelman, A.H. Hamrahian, Medical and surgical evaluation and treatment of adrenal incidentalomas. J. Clin. Endocrinol. Metab. 96(7), 2004-2015 (2011)
23. A. Comlekci, S. Yener, S. Ertilav et al., Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience. Endocrine 37(1), 40-46 (2010)
24. A.H. Ahmed, R.D. Gordon, P.J. Taylor et al., Effect of contraceptives on aldosterone/renin ratio may vary according to the components of contraceptive, renin assay method, and possibly route of administration. J. Clin. Endocrinol. Metab. 96(6), 1797-1804 (2011)
25. G. Giachetti, P. Mulsyero, F. Mantero et al., Primary aldosteronism, a major form of lower renin hypertension: from screening to diagnosis. Trends Endocrinol. Metab. 19, 104-108 (2008)
26. M. Tzanela, G. Effremidis, D. Vassiliadi et al., The aldosterone to renin ratio in the evaluation of patients with incidentally detected adrenal masses. Endocrine 32(2), 136-142 (2007)
27. C. Kotliar, F. Inserra, P. Forcada et al., Are plasma renin activity and aldosterone levels useful as a screening test to differentiate between unilateral and bilateral renal artery stenosis in hypertensive patients? J. Hypertens. 28(3), 594-601 (2010)
28. UK Prospective Diabetes Study Group, Tight blood pressure control and risk of macrovascular complications in type 2 diabetes: UKPDS 38-UK Prospective Diabetes Study Group. BMJ 317(7160), 703-713 (1998)
29. L.A. Sechi, G. Colussi, A. Di Fabio et al., Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment. Am. J. Hypertens. 23(12), 1253-1260 (2010)